23 results match your criteria: "Orbassano and Infermi Hospital[Affiliation]"
Medicina (Kaunas)
November 2023
Interventional Cardiology Unit, San Luigi Gonzaga University Hospital, Orbassano and Infermi Hospital, 10098 Rivoli, Italy.
: Percutaneous left-atrial appendage (LAA) occlusion is an important therapeutic option for preventing cardioembolic stroke in patients with non-valvular atrial fibrillation (AF) at high risk of thromboembolic events and with contraindications for oral anticoagulation (OAC). It is usually performed with transesophageal echocardiography (TOE) guidance under general anesthesia (GA). In this retrospective study, we present a multicenter experience of LAA occlusion performed with conscious sedation (CS) without an anesthesiologist on site.
View Article and Find Full Text PDFInt J Cardiovasc Imaging
December 2022
Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, S. Anna, Via Aldo Moro 8, 44124, Cona, FE, Italy.
To test whether quantitative flow ratio (QFR)-based trans-stent gradient (TSG) is associated with adverse clinical events at follow-up. A post-hoc analysis of the multi-center HAWKEYE study was performed. Vessels post-PCI were divided into four groups (G) as follows: G1: QFR ≥ 0.
View Article and Find Full Text PDFJ Atr Fibrillation
August 2021
Department of Cardiac Electrophysiologist and Pacing, Istituto Clinico Sant'Ambrogio, Milan, Italy.
Background: The efficacy of posterior wall isolation (PWI) on top of pulmonary vein isolation (PVI) in patients affected by persistent atrial fibrillation (AF) is still controversial and little is known about the impact of contact-force (CF) technology.
Objective: In this retrospective study, we present our experience with PWI using CF sensing catheters and its efficacy and safety as an adjunctive ablation strategy on top of PVI for management of patients with persistent and longstanding persistent AF.
Methods: A total of 73 consecutive patients (20.
Cardiovasc Drugs Ther
August 2022
Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, Via Aldo Moro 8, 44124, Cona, FE, Italy.
Purpose: Wire-based coronary physiology pullback performed before percutaneous coronary intervention (PCI) discriminates coronary artery disease (CAD) distribution and extent, and is able to predict functional PCI result. No research investigated if quantitative flow ratio (QFR)-based physiology assessment is able to provide similar information.
Methods: In 111 patients (120 vessels) treated with PCI, QFR was measured both before and after PCI.
Background Women represent an increasing percentage of interventional cardiologists in Italy compared with other countries. However, gaps exist in understanding and adapting to the impact of these changing demographics. Methods and Results We performed a national survey to analyze demographics, gender-based professional difference, needs in terms of catheterization laboratory (Cath-Lab) abstention, and radiation safety issues in Italian Cath-Lab settings.
View Article and Find Full Text PDFAm Heart J
February 2020
Department of Cardiology, University of Torino, Italy.
Int J Cardiol
February 2020
Swiss Cardiovascular Center Bern, Bern University Hospital, Switzerland.
Am J Cardiovasc Drugs
June 2020
Division of Cardiology, Department of Medical Sciences, University of Torino, Turin, Italy.
JACC Cardiovasc Interv
October 2019
Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, Cona, Italy; Maria Cecilia Hospital, GVM Care & Research, Cotignola, Italy. Electronic address:
Objectives: The aim of this study was to investigate the potential role of post-percutaneous coronary intervention (PCI) quantitative flow ratio (QFR) measurements to predict clinical outcomes in patients with successful PCI.
Background: The prognostic value of QFR measured immediately after PCI has not been prospectively investigated.
Methods: Patients undergoing complete revascularization with successful PCI and stent implantation were eligible for acquisition of projections for QFR computation.
Cardiovasc Revasc Med
April 2020
Division of Cardiology, San Luigi Gonzaga University Hospital, Orbassano and Infermi Hospital, Rivoli, Turin, Italy.
Randomised trials have demonstrated higher midterm rates of adverse events and device thrombosis with Absorb-BVS compared to contemporary drug-eluting-stents (DES). BVS failure was ascribed to the implantation technique and consequently two large randomised trials evaluated the clinical impact of an optimised scaffold-implant-procedure. However, pooling together data from ABSORB-IV and those of the COMPARE-ABSORB, the scaffold was still associated with a statistically significant increased risk of target-vessel myocardial-infarction (OR 1.
View Article and Find Full Text PDFAm J Cardiovasc Drugs
August 2019
Department of Cardiology, Department of Medical Sciences, University of Torino, Turin, Italy.
Am J Cardiovasc Drugs
August 2019
Department of Cardiology, Department of Medical Sciences, University of Torino, Turin, Italy.
Background: Limited data are available concerning differences in clinical outcomes for real-life patients treated with ticagrelor versus prasugrel after percutaneous coronary intervention (PCI).
Objective: Our objective was to determine and compare the efficacy and safety of ticagrelor and prasugrel in a real-world population.
Methods: RENAMI was a retrospective, observational registry including the data and outcomes of consecutive patients with acute coronary syndrome (ACS) who underwent primary PCI and were discharged with dual antiplatelet therapy (DAPT) between January 2012 and January 2016.
Int J Cardiol
April 2019
Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy. Electronic address:
Background: Percutaneous coronary intervention (PCI) has been established as an alternative treatment option to coronary artery by-pass graft (CABG) surgery in patients with left main coronary artery disease (LMCAD). Whether the findings of randomized controlled trials are applicable to a real-world patient population is unclear.
Methods: We compared the outcomes of PCI with new-generation DES in the all-comer, international, multicenter DELTA-2 registry retrospectively evaluating mid-term clinical outcomes with the historical CABG cohort enrolled in the DELTA-1 registry according to the EXCEL key inclusion or exclusion criteria.
Int J Cardiol Heart Vasc
March 2019
Interventional Cardiology, San Luigi Gonzaga University Hospital, Orbassano and Infermi Hospital, Rivoli, Turin, Italy.
Introduction: The efficacy and safety of switching P2Y receptor antagonists in patients admitted for acute coronary syndrome (ACS) remain unclear. We assessed the short-term clinical outcomes (in-hospital and within 30 days) of switching P2Y inhibitor (P2YI) drugs versus maintaining the same regimen by performing a comprehensive review and meta-analysis of available data.
Methods: MEDLINE/PubMed/SCOPUS/Cochrane databases were screened for studies regarding switching of P2YI in patients with ACS that reported 30 days follow-up.
Int J Cardiol
December 2018
Department of Cardiology, University Hospital Álvaro Cunqueiro, Vigo, Spain.
Thromb Res
July 2018
Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
Introduction: Ticagrelor and prasugrel are recommended as first line therapy in patients with acute coronary syndromes (ACS). However, patients with anemia are commonly treated with clopidogrel in routine clinical practice. The RENAMI registry (REgistry of New Antiplatelet therapy in patients with acute Myocardial Infarction) included ACS patients treated with prasugrel or ticagrelor at hospital discharge.
View Article and Find Full Text PDFJACC Cardiovasc Interv
December 2017
Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy.
Objectives: The aim of this study was to evaluate clinical outcomes of unprotected left main coronary artery percutaneous coronary intervention (PCI) with new-generation drug-eluting stents in a "real world" population.
Background: PCI of the unprotected left main coronary artery is currently recommended as an alternative to coronary artery bypass grafting (CABG) in selected patients.
Methods: All consecutive patients with unprotected left main coronary artery stenosis treated by PCI with second-generation drug-eluting stents were analyzed in this international, all-comers, multicenter registry.
J Thorac Dis
August 2017
Laboratory of Invasive Cardiology, Santa Maria della Pietà Hospital, Nola, Napoli, Italy.
Bioresorbable vascular scaffolds (BRS) represent the latest innovation in the field of interventional cardiology. BRS have recently been introduced in routine clinical practice and their use has progressively extended in everyday clinical practice. The BRS use appears theoretically attractive in patients presenting with acute coronary syndromes (ACS) as they are generally young with long life expectancy, thus possibly benefiting more of the so-called vascular reparative therapy.
View Article and Find Full Text PDFInt J Cardiol
October 2017
Cardiological Department, Misericordia Hospital, Grosseto, Italy.
Aim: To compare in patients with ACS (acute coronary syndromes) a PCI (percutaneous coronary intervention) approach based on FFR (fractional flow reserve) vs. one based on OCT (optical coherence tomography).
Methods And Results: Consecutive patients admitted for ACS and treated with a PCI approach based on OCT or on FFR (recruited in two different studies) were compared and matched with propensity score analysis.
Cardiovasc Diabetol
May 2017
Unidad de Cardiología Intervencionista, Hospital Clínico San Carlos, 28040, Madrid, Spain.
Background: In diabetic patients a predisposed coronary microcirculation along with a higher risk of distal particulate embolization during primary percutaneous intervention (PCI) increases the risk of peri-procedural microcirculatory damage. However, new antiplatelet agents, in particular Ticagrelor, may protect the microcirculation through its adenosine-mediated vasodilatory effects.
Methods: PREDICT is an original, prospective, randomized, multicenter controlled study designed to investigate the protective effect of Ticagrelor on the microcirculation during PCI in patient with diabetes mellitus type 2 or pre-diabetic status.
Cardiovasc Interv Ther
July 2018
Interventional Cardiology, Hospital Clinico San Carlos, Calle Prof Martin Lagos s/n, 28040, Madrid, Spain.
Clin Cardiol
August 2017
Cardiovascular Institute, Hospital Clínico San Carlos and Department of Medicine, Complutense University, Madrid, Spain.
Unlabelled: Coronary artery aneurysm is defined as a coronary dilation that exceeds the diameter of adjacent segments or the diameter of the patient's largest normal coronary vessel by 1.5×. It is an uncommon disease that has been diagnosed with increasing frequency since the widespread appearance of coronary angiography.
View Article and Find Full Text PDF